# Antimicrobial Stewardship Principles

> Antimicrobial stewardship for MBBS Pharmacology: AWaRe classification, India red-line campaign, de-escalation rules and duration limits explained.

- Canonical URL: https://prepelephant.com/topics/mbbs/pharmacology/antimicrobial-stewardship-principles
- Exam / course: MBBS · Subject: Pharmacology
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-02
- Last updated: 2026-10-02
- How to cite: "Antimicrobial Stewardship Principles", PrepElephant, https://prepelephant.com/topics/mbbs/pharmacology/antimicrobial-stewardship-principles

## Direct answer

Every unnecessary antibiotic prescription selects resistant organisms — in the patient, the hospital and the community — and stewardship exists to slow that selection without denying needed therapy: right drug, right dose, right route, right duration, with de-escalation once cultures speak. Structurally, programmes combine formulary restriction and pre-authorisation for broad agents, prospective audit with feedback, intravenous-to-oral switching for highly bioavailable drugs, and hard duration limits — five days for community-acquired pneumonia, seven for ventilator-associated. The WHO's AWaRe classification sorts antibiotics into Access, Watch and Reserve; India operationalises the same ideas through the National Action Plan on AMR, ICMR surveillance and treatment guidelines, and the red-line campaign marking prescription-only antibiotic packs.

## What you must remember

- **AWaRe logic:** Access (first and second choice for common infections — WHO wants at least 70 per cent of national consumption here), Watch (broader, resistance-prone: fluoroquinolones, third-generation cephalosporins, carbapenems), Reserve (last resort: colistin, polymyxin B, ceftazidime-avibactam, tigecycline).
- **India's red line (2016):** a red vertical band on antibiotic strips marks Schedule H1 drugs — no prescription, no sale — a consumer-facing stewardship device worth quoting.
- **De-escalation:** broad empiric therapy narrows to the most targeted agent once culture and sensitivity return — fewer spectrum days, less selection pressure.
- **IV-to-oral switch:** fluoroquinolones, linezolid, fluconazole, metronidazole and doxycycline are highly bioavailable — convert when the patient is afebrile and eating.
- **PK/PD dosing:** beta-lactams are time-dependent (extended infusions maximise time above MIC); aminoglycosides are concentration-dependent (once daily); vancomycin targets AUC over MIC of 400-600.
- **Duration discipline:** community-acquired pneumonia 5 days, ventilator-associated pneumonia and complicated urinary infection 7, cellulitis 5-7 — shorter is equal when the patient is stable.
- **Surgical prophylaxis:** cefazolin within 60 minutes before incision (120 for vancomycin or fluoroquinolone), stopped within 24 hours — often a single dose.
- **Redundancy check:** no double anaerobic cover (metronidazole alongside piperacillin-tazobactam or a carbapenem), no duplicate spectra; and most "penicillin allergy" labels are false — assess and delabel.

## Auditing one prescription end to end

Take a post-operative patient started empirically on meropenem plus metronidazole for intra-abdominal sepsis. Day three: cultures grow Escherichia coli, susceptible to ceftriaxone, no anaerobes despite peritoneal soilage considerations resolved by source control — de-escalate to ceftriaxone, and the metronidazole's redundancy (meropenem already covered anaerobes) disappears with it. Day four: afebrile, eating — switch to oral. Day seven: stop, total course complete at the guideline duration. The audit trail shows every principle in one chart: empiric breadth justified by severity, narrowed by microbiology, converted by bioavailability, terminated by protocol rather than by habit or by the outpatient department's comfort.

Add the pharmacy-level view: every one of these doses should have crossed a red-line pack and a prescription — because in India the stewardship battlefield sits behind the chemist's counter as much as on the ward.

## The Indian programme landscape

India's National Action Plan on AMR (2017), aligned with the WHO global action plan, coordinates surveillance, infection control and stewardship; the ICMR's antimicrobial resistance surveillance network publishes the susceptibility data that should drive every hospital's empiric antibiotic policy — extended-spectrum beta-lactamase rates above 60 per cent in Indian E. coli isolates being the headline number that reorganised empiric therapy. Over-the-counter antibiotic sales remain the structural driver: pharmacists dispensing carbapenems without prescriptions make the red-line campaign and Schedule H1 registers as much consumer education as regulation. Hospital antibiotic stewardship committees are mandated under NABH accreditation; formulary restriction with pre-authorisation for Watch and Reserve agents is their sharpest tool. Report suspected resistance-driven failures and Clostridioides difficile diarrhoea to the PvPI.

## Frequently asked questions

### What are the three AWaRe categories?

Access — first-line agents for common infections; Watch — broader, resistance-prone drugs needing stewardship; Reserve — last-resort agents saved for multidrug-resistant infection.

### What does the red line on Indian antibiotic strips signify?

A Medicines-with-Red-Line mark identifying Schedule H1 antibiotics that must be sold only against a valid prescription — the 2016 campaign against over-the-counter sale.

### Why de-escalate empiric therapy once cultures return?

Narrowing to the most targeted agent preserves susceptibility ecology, reduces cost and toxicity, and shortens spectrum days without sacrificing outcomes.

### Which antibiotics allow early intravenous-to-oral switching?

Those with high oral bioavailability — fluoroquinolones, linezolid, fluconazole, metronidazole, doxycycline; beta-lactams generally do not.

### What is the recommended duration and timing of surgical prophylaxis?

Cefazolin within 60 minutes before incision, discontinued within 24 hours — frequently a single pre-operative dose suffices.
